Pralatrexate 65219-0552
Product NDC
65219-0552- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 15, 2022
- Listing Expires
- December 31, 2026
- Application
- NDA022468
Need to source Pralatrexate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pralatrexate | 40 mg/2mL |
Drug Class
Folate Analog Metabolic Inhibitor [EPC]Folate Analog Metabolic Inhibitor [EPC]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (65219-552-02) / 2 mL in 1 VIAL, SINGLE-DOSE